Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus

Journal of Molecular Endocrinology

Volumn 41, Issue 3-4, 2008, Pages 205-217

  Davis, Angela M ^a   Mao, Jiude ^a   Naz, Bushra ^a   Kohl, Jessica A ^a   Rosenfeld, Cheryl S ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; ESTRADIOL; FULVESTRANT; KALLIKREIN; METHYLPIPERIDINOPYRAZOLE; PROTEIN CDC451; PROTEIN CDCA8; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SONIC HEDGEHOG PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA REPLICATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; GENE NUMBER; GENE REPRESSION; LOW DRUG DOSE; MICROARRAY ANALYSIS; MONOTHERAPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; UTERUS;

ANIMALS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIECTOMY; PIPERIDINES; PYRAZOLES; RALOXIFENE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERUS;

EID: 55749100290     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-08-0029     Document Type: Article

References (86)

1. Andrade PM, Silva ID, Borra RC, Lima GR & Baracat EC 2002 Estrogen and selective estrogen receptor modulator regulation of insulin-like growth factor binding protein 5 in the rat uterus. Gynecological Endocrinology 16 265-270.
2. Borras M, Hardy L, Lempereur F, el Khissiin AH, Legros N, Gol-Winkler R & Leclercq G 1994 Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. Journal of Steroid Biochemistry and Molecular Biology 48 325-336.
3. Cano A & Hermenegildo C 2000 The endometrial effects of SERMs. Human Reproduction Update 6 244-254.
4. Carthew P, Edwards RE & Nolan BM 1999 Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse. Toxicology and Applied Pharmacology 158 24-32.
5. Castro-Rivera E & Safe S 1998 Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture. Journal of Steroid Biochemistry and Molecular Biology 64 287-295.
6. Chan S 2002 A review of selective estrogen receptor modulators in the treatment of breast and endometrial cancer. Seminars in Oncology 29 129-133.
7. Chen Y, Jefferson WN, Newbold RR, Padilla-Banks E & Pepling ME 2007 Estradiol, progesterone, and genistein inhibit oocyte nest breakdown and primordial follicle assembly in the neonatal mouse ovary in vitro and in vivo. Endocrinology 148 3580-3590.
8. Chin M, Isono M, Isshiki K, Araki S, Sugimoto T, Guo B, Sato H, Haneda M, Kashiwagi A & Koya D 2005 Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. American Journal of Pathology 166 1629-1636.
9. Clements J & Mukhtar A 1997 Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers. Immunopharmacology 36 217-220.
10. Cowley SM, Hoare S, Mosselman S & Parker MG 1997 Estrogen receptors alpha and beta form heterodimers on DNA. Journal of Biological Chemistry 272 19858-19862.
11. Dardes RC, Schafer JM, Pearce ST, Osipo C, Chen B & Jordan VC 2002 Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells. Gynecologic Oncology 85 498-506.
12. Davis AM, Ellersieck MR, Grimm KM & Rosenfeld CS 2006 The effects of the selective estrogen receptor modulators, methyl-piperidino- pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus. Molecular Reproduction and Development 73 1034-1044.
13. Diel P, Smolnikar K, Schulz T, Laudenbach-Leschowski U, Michna H & Vollmer G 2001 Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Human Reproduction 16 997-1006.
14. Dukes M, Waterton JC & Wakeling AE 1993 Antiuterotrophic effects of the pure antioestrogen ICI 182,780 in adult female monkeys (Macaca nemestrina): quantitative magnetic resonance imaging. Journal of Endocrinology 138 203-210.
15. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P & Mark M 2000 Effect of single and compound knockouts of estrogen receptors alpha (ERα) and beta (ERβ) on mouse reproductive phenotypes. Development 127 4277-4291.
16. Fertuck KC, Eckel JE, Gennings C & Zacharewski TR 2003 Identification of temporal patterns of gene expression in the uteri of immature, ovariectomized mice following exposure to ethynylestradiol. Physiological Genomics 15 127-141.
17. Fong CJ, Burgoon LD, Williams KJ, Forgacs AL & Zacharewski TR 2007 Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice. BMC Genomics 8 151.
18. Forman BM, Umesono K, Chen J & Evans RM 1995 Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81 541-550.
19. Galand P, Leroy F & Chretien J 1971 Effect of oestradiol on cell proliferation and histological changes in the uterus and vagina of mice. Journal of Endocrinology 49 243-252.
20. Glidewell-Kenney C, Hurley LA, Pfaff L, Weiss J, Levine JE & Jameson JL 2007 Nonclassical estrogen receptor a signaling mediates negative feedback in the female mouse reproductive axis. PNAS.
21. Green AR, Parrott EL, Butterworth M, Jones PS, Greaves P & White IN 2001 Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus. Journal of Endocrinology 170 555-564.
22. Gresack JE, Kerr KM & Frick KM 2007 Short-term environmental enrichment decreases the mnemonic response to estrogen in young, but not aged, female mice. Brain Research 1160 91-101.
23. Gustafsson JA 1998 Raloxifene: magic bullet for heart and bone? Nature Medicine 4 152-153.
24. Gutman M, Couillard S, Roy J, Labrie F, Candas B & Labrie C 2002 Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremilene, droloxifene, idoxifene, GW-5638 and raloxilene on the growth of human ZR-75-1 breast tumors in nude mice. International Journal of Cancer 99 273-278.
25. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA & Katzenellenbogen BS 2003 Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Molecular and Cellular Endocrinology 206 13-22.
26. Hatsumi T & Yamamuro Y 2006 Downregulation of estrogen receptor gene expression by exogenous 17β-estradiol in the mammary glands of lactating mice. Experimental Biology and Medicine 231 311-316.
27. Helvering LM, Adrian MD, Geiser AG, Estrem ST, Wei T, Huang S, Chen P, Dow ER, Calley JN, Dodge JA et al. 2005 Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus. Biology of Reproduction 72 830-841.
28. Hewitt SC, Deroo BJ, Hansen K, Collins J, Grissom S, Afshari CA & Korach KS 2003 Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Molecular Endocrinology 17 2070-2083.
29. Hong EJ, Park SH, Choi KC, Leung PC & Jeung EB 2006 Identification of estrogen-regulated genes by microarray analysis of the uterus of immature rats exposed to endocrine disrupting chemicals. Reproductive Biology and Endocrinology 4 49.
30. Howell A, Osborne CK, Morris C & Wakeling AE 2000 ICI 182,780 (Faslodex): development of a novel 'pure' antiestrogen. Cancer 89 817-825.
31. Jones LA & Bern HA 1977 Long-term effects of neonatal treatment with progesterone, alone and in combination with estrogen, on the mammary gland and reproductive tract of female BALB/cfC3H mice. Cancer Research 37 67-75.
32. Jordan VC 2003 Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. Journal of Medicinal Chemistry 46 1081-1111.
33. Katayama S, Ashizawa K, Gohma H, Fukuhara T, Narumi K, Tsuzuki Y, Tatemoto H, Nakada T & Nagai K 2006 The expression of Hedgehog genes (Ihh, Dhh) and Hedgehog target genes (Ptc1, Gli1, Goup-TfII) is affected by estrogenic stimuli in the uterus of immature female rats. Toxicology and Applied Pharmacology 217 375-383.
34. Kaye AM, Spatz M, Waisman A, Sasson S, Tamir S, Vaya J & Somjen D 2001 Paradoxical interactions among estrogen receptors, estrogens and SERMS: mutual annihilation and synergy. Journal of Steroid Biochemistry and Molecular Biology 76 85-93.
35. Khalyfa A, Klinge CM, Hall WC, Zhao X, Miller MM & Wang E 2003 Transcription profiling of estrogen target genes in young and old mouse uterus. Experimental Gerontology 38 1087-1099.
36. Komm BS, Nagpal S, Chang KC, Berrodin TJ, Freedman LP & McDonell DP 2007 Tissue selective estrogen complexes (TSECs): optimal menopausal therapy. In The Endocrine Society 89th Annual Meeting, Toronto, CA. Abstract # OR38-31.
37. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA & Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor beta. PNAS 95 15677-15682.
38. Kuiper GG & Gustafsson JA 1997 The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Letters 410 87-90.
39. Lee AE 1980 The proliferative action of oestriol. Journal of Endocrinology 84 289-294.
40. Leung YK, Mak P, Hassan S & Ho SM 2006 Estrogen receptor (ER)-β isoforms: a key to understanding ER-β signaling. PNAS 103 13162-13167.
41. Li X, Huang J, Yi P, Bambara RA, Hilf R & Muyan M 2004 Single-chain estrogen receptors (ERs) reveal that the ERα/β heterodimer emulates functions of the ERα dimer in genomic estrogen signaling pathways. Molecular and Cellular Biology 24 7681-7694.
42. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS & Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene, PNAS 90 11162-11166.
43. Mai Z, Blackburn GL & Zhou JR 2007 Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice. Carcinogenesis 28 1217-1223.
44. Martin LA, Pancholi S, Chan CM, Farmer I, Kimberley C, Dowsett M & Johnston SR 2005 The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling. Endocrine-Related Cancer 12 1017-1036.
45. Matthews J & Gustafsson JA 2003 Estrogen signaling: a subtle balance between ER α and ER β. Molecular Interventions 3 281-292.
46. McDougall KE, Perry MJ, Gibson RL, Colley SM, Korach KS & Tobias JH 2003 Estrogen receptor-alpha dependency of estrogen's stimulatory action on cancellous bone formation in male mice. Endocrinology 144 1994-1999.
47. van Meeuwen JA, van den Berg M, Sanderson JT, Verhoef A & Piersma AH 2007 Estrogenic effects of mixtures of phyto- and synthetic chemicals on uterine growth of prepubertal rats. Toxicology Letters 170 165-176.
48. Monroe DG, Secreto FJ, Subramaniam M, Getz BJ, Khosla S & Spelsberg TC 2005 Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells. Molecular Endocrinology 19 1555-1568.
49. Naciff JM, Torontali SM, Overmann GI, Carr GJ, Tiesman JP & Daston GP 2005 Evaluation of the gene expression changes induced by 17-α-ethynyl estradiol in the immature uterus/ovaries of the rat using high density oligonucleotide arrays. Birth Defects Research. Part B, Developmental and Reproductive Toxicology 74 164-184.
50. Nephew KP, Long X, Osborne E, Burke KA, Ahluwalia A & Bigsby RM 2000 Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biology of Reproduction 62 168-177.
51. Paszkiewicz-Gadek A, Porowska H, Pietruczuk M, Haczynski J, Kisiel DG & Wolczynski S 2005 Effect of estradiol and raloxifene on MUC1 expression and adhesive properties of Ishikawa cells. Oncology Reports 14 583-589.
52. Pentecost BT & Teng CT 1987 Lactotransferrin is the major estrogen inducible protein of mouse uterine secretions. Journal of Biological Chemistry 262 10134-10139.
53. Pettersson K, Grandien K, Kuiper GG & Gustafsson JA 1997 Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Molecular Endocrinology 11 1486-1496.
54. Pillai SB, Jones JM & Koos RD 2002 Treatment of rats with 17β-estradiol or relaxin rapidly inhibits uterine estrogen receptor beta1 and β2 messenger ribonucleic acid levels. Biology of Reproduction 67 1919-1926.
55. Pinto PI, Singh PB, Condeca JB, Teodosio HR, Power DM & Canario AV 2006 ICI 182,780 has agonistic effects and synergizes with estradiol-17 β in fish liver, but not in testis. Reproductive Biology and Endocrinology 4 67.
56. Punyadeera C, Dassen H, Klomp J, Dunselman G, Kamps R, Dijcks F, Ederveen A, de Goeij A & Groothuis P 2005 Oestrogen-modulated gene expression in the human endometrium. Cellular and Molecular Life Sciences 62 239-250.
57. Rajapakse S, Yamano N, Ogiwara K, Hirata K, Takahashi S & Takahashi T 2007 Estrogen-dependent expression of the tissue kallikrein gene (Klk1) in the mouse uterus and its implications for endometrial tissue growth. Molecular Reproduction and Development 74 1053-1063.
58. Robertson JA, Zhang Y & Ing NH 2001 ICI 182,780 acts as a partial agonist and antagonist of estradiol effects in specific cells of the sheep uterus. Journal of Steroid Biochemistry and Molecular Biology 77 281-287.
59. Saitta A, Morabito N, Frisina N, Cucinotte D, Corrado F, D'Anna R, Altavilla D, Squadrito G, Minutoli L, Arcoraci V et al. 2001 Cardiovascular effects of raloxifene hydrochloride. Cardiovascular Drug Reviews 19 57-74.
60. SAS 1988 SAS/STAT User's Guide, Cary, NC: SAS Institute, Inc.
61. Schafer JI, Liu H, Tonetti DA & Jordan VC 1999 The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptor. Cancer Research 59 4308-4313.
62. Shughrue PJ, Lane MV, Scrimo PJ & Merchenthater I 1998 Comparative distribution of estrogen receptor-alpha (ER-α) and β (ER-β) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 63 498-504.
63. Sismondi P, Biglia N, Ponzone R, Fuso L, Scafoglio C, Cicatiello L Ravo M, Weisz A, Cimino D, Altobelli G et al. 2007 Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes. Maturitas 57 50-55.
64. Sivridis E, Giatromanolaki A, Koukourakis MI, Georgiou L & Anastasiadis P 2002 Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance. Histopathology 40 92-100.
65. Skern R, Frost P & Nilsen F 2005 Relative transcript quantification by quantitative PCR: roughly right or precisely wrong? BMC Molecular Biology 6 10.
66. Snyder KR, Sparano N & Malinowski JM 2000 Raloxifene hydrochloride. American Journal of Health-System Pharmacy 57 1669-1675.
67. Spencer CP, Morris EP & Rymer JM 1999 Selective estrogen receptor modulators: women's panacea for the next millennium? American Journal of Obstetrics and Gynecology 180 763-770.
68. Stygar D, Muravitskaya N, Eriksson B, Eriksson H & Sahlin L 2003 Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus. Reproductive Biology and Endocrinology 1 40.
69. Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA & Katzenellenbogen BS 2002 Antagonists selective for estrogen receptor alpha. Endocrinology 143 941-947.
70. Sundstrom SA, Komm BS, Ponce-de-Leon H, Yi Z, Teuscher C & Lyttle CR 1989 Estrogen regulation of tissue-specific expression of complement C3. Journal of Biological Chemistry 264 16941-16947.
71. Surveyor GA, Gendler SJ, Pemberton L, Das SK, Chakraborty I, Julian J, Pimental RA, Wegner CC, Dey SK & Carson DD 1995 Expression and steroid hormonal control ofMuc-1 in the mouse uterus. Endocrinology 136 3639-3647.
72. Tanos V, Brzezinski A, Drize O, Strauss N & Peretz T 2002 Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. European Journal of Obstetrics, Gynecology and Reproductive Biology 102 188-194.
73. Thakur MK & Sharma PK 2007 Transcription of estrogen receptor alpha and beta in mouse cerebral cortex: effect of age, sex, 17β-estradiol and testosterone. Neurochemistry International 50 314-321.
74. Watanabe H, Suzuki A, Kobayashi M, Lubahn DB, Handa H & Iguchi T 2003a Similarities and differences in uterine gene expression patterns caused by treatment with physiological and non-physiological estrogens. Journal of Molecular Endocrinology 31 487-497.
75. Watanabe H, Suzuki A, Kobayashi M, Takahashi E, Itamoto M, Lubahn DB, Handa H & Iguchi T 2003b Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. Journal of Molecular Endocrinology 30 347-358.
76. Watanabe H, Suzuki A, Goto M, Lubahn DB, Handa H & Iguchi T 2004 Tissue-specific estrogenic and non-estrogenic effects of a xenoestrogen, nonylphenol. Journal of Molecular Endocrinology 33 243-252.
77. Willard ST & Frawley LS 1998 Phytoestrogens have agonistic and combinatorial effects on estrogen-responsive gene expression in MCF-7 human breast cancer cells. Endocrine 8 117-121.
78. Wittmann BM, Sherk A & McDonnell DP 2007 Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators. Cancer Research 67 9549-9560.
79. Wong SP, Li J, Shen P, Gong Y, Yap SP & Yong EL 2007 Ultrasensitive cell-based bioassay for the measurement of global estrogenic activity of flavonoid mixtures revealing additive, restrictive, and enhanced actions in binary and higher order combinations. Assay and Drug Development Technologies 5 355-362.
80. Wu J, Liang Y, Nawaz Z & Hyder SM 2005 Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-β: implications for treatment resistance. International Journal of Oncology 27 1647-1659.
81. Yamamoto Y, Moore R, Hess HA, Guo GL, Gonzalez FJ, Korach KS, Maronpot RR & Negishi M 2006 Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity. Journal of Biological Chemistry 281 16625-16631.
82. Yamashita S, Newbold RR, McLachlan JA & Korach KS 1990 The role of the estrogen receptor in uterine epithelial proliferation and cytodifferentiation in neonatal mice. Endocrinology 127 2456-2463.
83. Yanaihara A, Otsuka Y, Iwasaki S, Aida T, Tachikawa T, Irie T & Okai T 2005 Differences in gene expression in the proliferative human endometrium. Fertility and Sterility 83 (Suppl 1) 1206-1215.
84. Zhao L, O'Neill K & Brinton RD 2006 Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. Journal of Pharmacology and Experimental Therapeutics 319 1124-1132.
85. Zheng H, Kangas L & Harkonen PL 2004 Comparative study of the short-term effects of a novel selective estrogen receptor modulator, ospemifene, and raloxifene and tamoxifen on rat uterus. Journal of Steroid Biochemistry and Molecular Biology 88 143-156.
86. Zou K & Ing NH 1998 Oestradiol up-regulates oestrogen receptor, cyclophilin, and glyceraldehyde phosphate dehydrogenase mRNA concentrations in endometrium, but down-regulates them in liver. Journal of Steroid Biochemistry and Molecular Biology 64 231-237.